C.ANIRUDH JAGANNADH, M.SRAVANI, and DR M.D DHANARAJU, “ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA/GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS”, ijpbs, vol. 4, no. 2, pp. 750–754, Jun. 2013.